What is the Ownership and Shareholding Structure of Scl Lifesciences?
In 2024, Scl Lifesciences had a promoter holding of 83.37% and a public holding of 16.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.










Company Details
+91-XXXXXXXXXX